| ZFIN ID: ZDB-EXP-180221-4 |
Experiment Conditions Description: chemical treatment: leukotriene B4
| chemical treatment: leukotriene B4 |
|---|
| Name: | chemical treatment |
|---|---|
| Synonyms: | |
| Definition: | Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000111] |
| Name: | leukotriene B4 |
|---|---|
| Synonyms: | (5S,12R,6Z,8E,10E,14Z)-5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid, (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyeicosa-6,8,10,14-tetraenoic acid, (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid, (S-(R*,S*-(E,Z,E,Z)))-5,12-Dihydroxy-6,8,10,14-eicosatetraenoic acid, 5(S),12(R)-dihydroxy-6(Z),8(E),10(E),14(Z)-eicosatetraenoic acid, 5(S),12(R)-dihydroxy-6(Z),8(E),10(E),14(Z)-icosatetraenoic acid, 5,12-Dihete, 5,12-Hete, 5S,12R-diHETE, 5S,12R-dihydroxy-6Z,8E,10E,14Z-eicosatetraenoic acid, Leukotriene B4, LTB4 |
| Definition: | A leukotriene composed of (6Z,8E,10E,14Z)-icosatetraenoic acid having (5S)- and (12R)-hydroxy substituents. It is a lipid mediator of inflammation that is generated from arachidonic acid via the 5-lipoxygenase pathway. |
| Ontology: | ChEBI [CHEBI:15647] ( EBI ) |
| Publication: | Demy et al., 2017 |
|---|